CVS Caremark to support St. Jude Children’s Research Hospital via annual in-store fundraiser
WOONSOCKET, R.I. — CVS/pharmacy has announced its annual in-store fundraiser for the 10th year to support the St. Jude Children’s Research Hospital Thanks and Giving campaign, a holiday program to raise awareness and funds for the research and care provided at St. Jude.
Since the campaign’s inception, CVS/pharmacy and its customers have raised more than $37 million to support St. Jude.
Through Dec. 7, CVS Caremark colleagues will encourage customers to add $1 or $3 to their purchase at the register to support the campaign. Customers shopping online at CVS.com/StJude will also have the opportunity to donate $1 at checkout.
"CVS/pharmacy is proud of its customers and colleagues who for nearly a decade have made a significant impact in the lives of children living with cancer and other deadly diseases through their generous support of the Thanks and Giving campaign," Eileen Howard Boone, SVP of corporate philanthropy and social responsibility at CVS Caremark said. "As a pharmacy innovation company committed to helping people on their path to better health, we commend St. Jude Children’s Research Hospital for all the work they are doing to treat children with cancer and the lifesaving research they share with experts across the world to help find cures."
In 2012, CVS/pharmacy customers and colleagues raised nearly $6.4 million nationwide in support of the St. Jude Children’s Research Hospital Thanks and Giving Campaign and more than $37 million since 2004.
Funds raised during the Thanks and Giving campaign support the CVS Caremark Rehabilitation Services Center at St. Jude. Children with deadly diseases such as cancer may experience developmental, cognitive or physical impairments because of their illnesses as well as the treatments used to save their lives. The facility in Memphis, Tenn., which opened in 2009, doubled the space dedicated to providing audiology, occupational therapy, physical therapy and speech-language pathology services to St. Jude patients to help them overcome barriers they face in recovery.
Report: Walgreens strengthens marketshare in key Charlotte metropolitan market with Kerr acquisition
TAMPA, Fla. — Chain Store Guide on Friday released its latest analysis on the recently-completed Kerr Drug acquisition by Walgreens. Walgreens had announced that 20 of Kerr Drug’s 76 locations would be closed, with 16 of those prescription files transferred to Walgreens locations and the remainder to other pharmacies.
According to CSG, Walgreens will strengthen its market share position in the Charlotte metro area. Fielding 44 core Walgreens locations, Walgreens will increase its pharmacy market share to 22.7%, according to Chain Store Guide’s 2013 Drug Industry Market Share Report published in August 2013.
CVS/Caremark’s market share within Charlotte is 37.6% with 75 locations and Rite Aid’s share is 16.2% with 51 locations.
CVS Caremark names EVP, health plans
WOONSOCKET, R.I. — CVS Caremark has announced the appointment of Tracy Bahl as EVP, health plans, leading the teams responsible for supporting health plan clients and offering health plans guidance to help them navigate the evolving health care marketplace.
"As health care reform continues to spur unprecedented and rapid changes across the health care system, CVS Caremark is focused on providing health plans with value and insights to help them manage the increasing complexity of the marketplace," Jon Roberts, president of the PBM business at CVS Caremark said. "Tracy is a great addition to our team and we look forward to working with him to continue to develop innovative solutions and offerings for health plans."
Known for his deep customer focus and relationship-building skills, Bahl brings to CVS Caremark nearly 30 years of experience as a health care executive with a strong track record of delivering results in leadership positions. He spent 10 years at UnitedHealth Group, where he served as the CEO of the Uniprise division, which encompassed the company’s national accounts business, consumer health business, financial services business, and service and technology operations.
He also worked for CIGNA Healthcare in a variety of regional and national health plan roles. Most recently, Bahl worked for General Atlantic, a global growth equity investment firm, where he supported a number of portfolio companies and investment activities in the health care space as a special advisor on the health care team. One of his primary roles was serving as executive chairman of Emdeon, playing a key role in its growth and subsequent sale.